|
|
|
|
LEADER |
00874nam 2200325#c 4500 |
001 |
UMA-3436 |
003 |
UMA |
005 |
20230415 193457 |
008 |
030304suuuu####sz###########||||#0#eng#d |
336 |
|
|
|a texto
|
337 |
|
|
|a no mediado
|
338 |
|
|
|a volumen
|
901 |
|
|
|a 6483
|
020 |
|
|
|a 9241545364
|
080 |
|
|
|a 615.11
|
092 |
|
|
|a REF. 615.11
|
245 |
|
|
|a The international pharmacopoeia
|
110 |
|
|
|a World Health Organization
|
650 |
|
|
|a Farmacopea
|
650 |
|
|
|a Farmacia
|
650 |
|
|
|a Pruebas
|
650 |
|
|
|a Métodos
|
650 |
|
|
|a Normas de calidad
|
650 |
|
|
|a Sustancias farmacéuticas
|
041 |
|
|
|a eng
|
044 |
|
|
|a sz#
|
500 |
|
|
|a Contenido: v.5 Test and general requirements for dosage formas ; Quality specifications for pharmaceutical substances and tablets
|
300 |
|
|
|a v. 5 ; 24 cm.
|
260 |
|
|
|a Geneva, Switzerland
|b WHO
|c 2003
|
250 |
|
|
|a 3rd. ed.
|